{
  "success": true,
  "enriched": 37,
  "total_entities": 368,
  "by_type": {
    "StudyArm": 2,
    "EligibilityCriterion": 16,
    "Objective": 7,
    "Endpoint": 12
  },
  "enriched_items": [
    {
      "type": "StudyArm",
      "name": "Active Comparator A: Diagnosis by Molecular Testing",
      "arm_type": "Active Comparator Arm",
      "nci_code": "C174267"
    },
    {
      "type": "StudyArm",
      "name": "Active Comparator B: Diagnosis by Conventional Testing",
      "arm_type": "Active Comparator Arm",
      "nci_code": "C174267"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Age requirement",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "cUTI signs and symptoms",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Evidence of pyuria",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "cUTI requiring diagnosis and treatment",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Active UTI or high-risk population",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Urine sample provision",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Sexual abstinence or condom use",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Protocol compliance",
      "category": "Inclusion",
      "nci_code": "C25532"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Informed consent",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "English language requirement",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Prior clinical trial participation",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Chronic antibiotic use",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Recent UTI antibiotic treatment",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Fetal congenital anomaly",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Life-threatening illness",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "EligibilityCriterion",
      "name": "Investigator judgment",
      "category": "Exclusion",
      "nci_code": "C25370"
    },
    {
      "type": "Objective",
      "name": "Primary Objective - Symptomatic Response Evaluatio",
      "level": "Trial Primary Objective",
      "nci_code": "C85826"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Antibiotic Selection Efficac",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Clinical Utility Assessment",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Antimicrobial Susceptibility",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Diagnostic Agreeability",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Secondary Objective - Discordant Results Assessmen",
      "level": "Trial Secondary Objective",
      "nci_code": "C85827"
    },
    {
      "type": "Objective",
      "name": "Exploratory Objective - Clinically Insignificant I",
      "level": "Trial Exploratory Objective",
      "nci_code": "C163559"
    },
    {
      "type": "Endpoint",
      "name": "Primary Endpoint - Favorable Clinical Outcomes",
      "level": "Primary Outcome Measure",
      "nci_code": "C98772"
    },
    {
      "type": "Endpoint",
      "name": "Secondary Endpoint - Microbiological Eradication",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Secondary Endpoint - Treating Investigator Satisfa",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Secondary Endpoint - Turnaround Time",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Secondary Endpoint - Diagnostic Agreeability",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Secondary Endpoint - Discordant Results Clinical O",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Exploratory Endpoint - Negative Percent Agreement",
      "level": "Exploratory Outcome Measure",
      "nci_code": "C98724"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoint - Clinical Observations",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoint - Vital Sign Measurements",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoint - Laboratory Tests",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoint - Reported Adverse Events",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    },
    {
      "type": "Endpoint",
      "name": "Safety Endpoint - Treatment Emergent Adverse Event",
      "level": "Secondary Outcome Measure",
      "nci_code": "C98781"
    }
  ],
  "cache_stats": {
    "total_entries": 50,
    "fresh_entries": 50,
    "stale_entries": 0,
    "cache_file": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\core\\evs_cache\\nci_codes.json"
  }
}